A National Cancer Institute Comprehensive Cancer Center

 
Patients & Families
Health Care Professionals
Researchers
Donors & Volunteers
Employees
 

Cancer Care

 

 

Extracorporeal Photopheresis

The Blood Donor Program, under the direction of Dr. Zbigniew M. Szczepiorkowski, MD, PhD, offers Extracorporeal Photopheresis (ECP) as a treatment option for Cutaneous T-cell lymphoma (CTCL) and for some forms of graft versus host disease (GVHD) in transplant patients.

Contact Us
  • Lebanon, NH (DHMC)
    Phone: (603) 650-4628
    Fax: (603) 650-2334
    Email Us
  • Cancer Help Line
    Toll-Free
    Phone: (800) 639-6918

ECP is an innovative cellular therapy that uses the THERAKOS UVAR® XTS™ Photopheresis instrument, a system designed specifically for this procedure.

  • In this procedure, a small portion of the patient's white blood cells is collected, treated with a medicine (methoxsalen) that is then activated by brief exposure to UVA (ultraviolet-A) light, and then promptly returned to the blood stream.
  • Photopheresis is done in repeated treatments that may gradually reduce symptoms over time.
  • It is typically done on an outpatient basis, and each treatment takes about three to four hours.

Contact the Blood Donor Program at (603) 653-3775 for more information.